Please login to the form below

Not currently logged in

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla


Bayer HealthCare has partnered with women's magazine Glamour for a campaign to celebrate the achievements of women in the US via a national competition.

The partners launched the Skyla Make Your Mark contest this week, which aims to seek out women who are pursuing something unique or brave, inspiring others along the way.

Skyla – the product that gives its name to the contest - is an IUD contraceptive marketed by Bayer Healthcare. It was introduced to the market in 2013.

Entrants must submit a brief essay and photo or video about how they are making their mark to the Glamour website. The winner will be awarded a $5,000 grant, a trip to New York to attend Glamour's Women of the Year gala and will be featured on a promotional page in an upcoming issue of the magazine.

To help promote the contest, Bayer Healthcare and Glamour have enlisted the actress Zosia Mamet from HBO TV series Girls.

Mamet, said: “We all have stories and they all deserve to be heard. Glamour, Bayer and I want to give women a platform to share their stories and to show the world how they're making their mark. We all make our marks in different ways.”

'Make Your Mark' closes on October 1, 2014.

Article by
Kirstie Pickering

11th September 2014

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....